CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2018; 39(01): 93-95
DOI: 10.4103/ijmpo.ijmpo_138_16
Case Report

A Case of Alveolar Rhabdomyosarcoma with Multifocal Pyomyositis Following Chemotherapy

Vibhor Sharma
Department of Medical Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, India
,
TS Subi
Department of Surgical Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, India
,
Debashish Chaudhary
Department of Surgical Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, India
,
Mehul Patel
Department of Radiodiagnosis, Homi Bhabha Cancer Hospital, Sangrur, Punjab, India
› Author Affiliations
Financial support and sponsorship Nil.

Abstract

Pyomyositis is extremely rare after chemotherapy for nonhematological malignancies. We report a patient of alveolar rhabdomyosarcoma, who developed multifocal pyomyositis in bilateral lower limbs after the first cycle of neoadjuvant chemotherapy with vincristine, ifosfamide, mesna, and etoposide. The diagnosis of pyomyositis was reached after ultrasound and contrast-enhanced computed tomography scan of bilateral lower limbs. Staphylococcus and Streptococcus were isolated from pus. This patient was treated with 4 weeks of antibiotics, besides ultrasound-guided pus aspiration and open surgical debridement. To the best of our knowledge, no case of rhabdomyosarcoma with pyomyositis following chemotherapy has been reported so far.



Publication History

Article published online:
23 June 2021

© 2018. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Kao KL, Hung GY, Hwang B. Pyomyositis during induction chemotherapy for acute lymphoblastic leukemia. J Chin Med Assoc 2006; 69: 184-8
  • 2 Fukushima T, Iwao H, Nakazima A, Miki M, Sakai T, Sawaki T. et al. MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy. Anticancer Res 2009; 29: 3361-4
  • 3 Tsai SH, Chao TY, Chou TD, Dai MS. Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient. Ann Hematol 2003; 82: 452-4
  • 4 Singh P, Chan W, Blomfield P, McIntosh R. Pyomyositis after chemotherapy for endometrial cancer. Int J Gynecol Cancer 2010; 20: 1256-8
  • 5 Yamada K, Wasa J, Sugiura H, Horio Y. A case of multiple pyomyositis after chemotherapy for lung cancer. Gan To Kagaku Ryoho 2006; 33: 837-40
  • 6 Keith BD, Bramwell VH. Pyomyositis after chemotherapy for breast cancer. Am J Clin Oncol 2000; 23: 42-4
  • 7 Chiu SK, Lin JC, Wang NC, Peng MY, Chang FY. Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis. J Microbiol Immunol Infect 2008; 41: 286-93
  • 8 Maguire J, Kaye SB. et al. Psoas abscess: Unusual complication of effective chemotherapy for teratoma. Br Med J (Clin Res Ed) 1985; 290: 1870
  • 9 Chiedozi LC. Pyomyositis Review of 205 cases in 112 patients. Am J Surg 1979; 137: 255-9
  • 10 Gubbay AJ, Isaacs D. Pyomyositis in children. Pediatr Infect Dis J 2000; 19: 1009-12